The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain
Abstract
The sustained administration of the 5‐HT 1A agonist gepirone (15 mg/kg/day, s.c.) in the rat produced an initial decrease of the firing activity of dorsal raphe 5‐HT neurons which was followed by a progressive recovery to normal after 14 days of treatment. At this point in time, the effect of intravenous lysergic acid diethylamide (LSD) on the firing activity of 5‐HT neurons was markedly reduced, whereas those of 8‐hydroxy‐2‐N, N‐propylamino‐tetralin (8‐OH‐DPAT) and of gepirone were unchanged; however, the responsiveness of 5‐HT neurons to direct microintophoretic application of 5‐HT, LSD, 8‐OH‐DPAT, and gepirone, but not of GABA, was reduced. The responsiveness of postsynaptic dorsal hippocampus pyramidal neurons to 5‐HT, 8‐OH‐DPAT, and gepirone was not altered by the 14‐day gepirone treatment. The effectiveness of the electrical stimulation of the ascending 5‐HT pathway in reducing pyramidal neuron firing activity was not significantly modified in rats treated with gepirone for 14 days. Furthermore, this treatment did not alter the function of the terminal 5‐HT autoreceptor. It is concluded that the progressive restoration of the firing activity of 5‐HT neurons, due to a desensitization of the somatodendritic 5‐HT autoreceptor, combined with the direct activation of normosensitive postsynaptic 5‐HT 1A receptor by gepirone, should result in an augmented tonic activation of postsynaptic 5‐HT 1A receptors. The progressive appearance of this phenomenon would be consistent with the time course of the clinical anxiolytic, and possibly antidepressant, effects of gepirone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site
Middlemiss, D. N., & Fozard, J. R. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90230-3 · Cited by 861
Electrophysiological responses of serotoninergic dorsal raphe neurons to 5‐HT1A and 5‐HT1B agonists
Sprouse, J. S., & Aghajanian, G. K. (1987) · Synapse · doi:10.1002/syn.890010103 · Cited by 845
ELECTROPHYSIOLOGY OF HIPPOCAMPAL NEURONS: II. AFTER-POTENTIALS AND REPETITIVE FIRING
Kandel, E. R., & Spencer, W. A. (1961) · Journal of Neurophysiology · doi:10.1152/jn.1961.24.3.243 · Cited by 688
Engel, G., G�thert, M., Hoyer, D., Schlicker, E., & Hillenbrand, K. (1986) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00633189 · Cited by 677
Andrade, R., & Nicoll, R. A. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016862 · Cited by 552
The comparative efficacy of buspirone and diazepam in the treatment of anxiety
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.9.1184 · Cited by 422
BLIER, P., de MONTIGNY, C., & CHAPUT, Y. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00003 · Cited by 404
Self-citation
Cited by
Cryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,119
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
5-HT1A receptor function in major depressive disorder
Savitz, J., Lucki, I., & Drevets, W. C. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.009 · Cited by 574
Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63799-1 · Cited by 543
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537
Self-citationIs there a role for 5-HT1A agonists in the treatment of depression?
Blier, P., & Ward, N. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01643-8 · Cited by 529
Self-citationThe therapeutic role of 5-HT1A and 5-HT2A receptors in depression
Celada, P., Puig, M. V., Amargós-Bosch, M., Adell, A., & Artigas, F. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0427 · Cited by 519
Riad, M., Garcia, S., Watkins, K. C., Jodoin, N., Doucet, �., Langlois, X., El Mestikawy, S., Hamon, M., & Descarries, L. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000207)417:2<181::aid-cne4>3.0.co;2-a · Cited by 513
Celada, P., Puig, M. V., Casanovas, J. M., Guillazo, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09917.2001 · Cited by 497
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462
5-HT1A receptor agonists: recent developments and controversial issues
De Vry, J. (1995) · Psychopharmacology · doi:10.1007/bf02245588 · Cited by 455
De Gregorio, D., McLaughlin, R. J., Posa, L., Ochoa-Sanchez, R., Enns, J., Lopez-Canul, M., Aboud, M., Maione, S., Comai, S., & Gobbi, G. (2019) · Pain · doi:10.1097/j.pain.0000000000001386 · Cited by 393
Mongeau, R., Blier, P., & de Montigny, C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00017-3 · Cited by 389
Self-citationForebrain Pathways Mediating Stress-Induced Hormone Secretion
Van de Kar, L. D., & Blair, M. L. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0172 · Cited by 380
Long-Term Antidepressant Treatments Result in a Tonic Activation of Forebrain 5-HT1AReceptors
Haddjeri, N., Blier, P., & de Montigny, C. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-10150.1998 · Cited by 332
Self-citationCelada, P., Bortolozzi, A., & Artigas, F. (2013) · CNS Drugs · doi:10.1007/s40263-013-0071-0 · Cited by 323
Sharp, T., Bramwell, S. R., & Grahame‐Smith, D. G. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11815.x · Cited by 321
Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors
Müller, C. P., Carey, R. J., Huston, J. P., & De Souza Silva, M. A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.01.001 · Cited by 302
Blier, P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00036-6 · Cited by 282
Self-citationRegulation of nausea and vomiting by cannabinoids
Parker, L. A., Rock, E. M., & Limebeer, C. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01176.x · Cited by 268
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Dawson, L. A., & Watson, J. M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00067.x · Cited by 262
Role of Somatodendritic 5‐HT Autoreceptors in Modulating 5‐HT Neurotransmissiona
BLIER, P., PIÑEYRO, G., EL MANSARI, M., BERGERON, R., & DE MONTIGNY, C. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10192.x · Cited by 261
Self-citationLe Poul, E., Laaris, N., Doucet, E., Laporte, A.-M., Hamon, M., & Lanfumey, L. (1995) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00176767 · Cited by 257
Rock, E., Bolognini, D., Limebeer, C., Cascio, M., Anavi‐Goffer, S., Fletcher, P., Mechoulam, R., Pertwee, R., & Parker, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01621.x · Cited by 255
Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei
Adell, A., Celada, P., Abellán, M. T., & Artigas, F. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00182-0 · Cited by 254
Quesseveur, G., David, D. J., Gaillard, M. C., Pla, P., Wu, M. V., Nguyen, H. T., Nicolas, V, Auregan, G., David, I., Dranovsky, A., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.30 · Cited by 235
Winstanley, C. A., Chudasama, Y., Dalley, J. W., Theobald, D. E. H., Glennon, J. C., & Robbins, T. W. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1398-x · Cited by 234
Haddjeri, N., De Montigny, C., & Blier, P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0700968 · Cited by 164
Self-citationIchimaru, Y., Egawa, T., & Sawa, A. (1995) · Japanese Journal of Pharmacology · doi:10.1254/jjp.68.65 · Cited by 163
Llado-Pelfort, L., Santana, N., Ghisi, V., Artigas, F., & Celada, P. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr220 · Cited by 156
Carrard, A., Salzmann, A., Malafosse, A., & Karege, F. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.018 · Cited by 138
Maisonnette, S., Morato, S., & Brandão, M. L. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90087-v · Cited by 130
Blier, P., Serrano, A., & Scatton, B. (1990) · Synapse · doi:10.1002/syn.890050206 · Cited by 123
Self-citationPharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113
De Gregorio, D., Posa, L., Ochoa-Sanchez, R., McLaughlin, R., Maione, S., Comai, S., & Gobbi, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.022 · Cited by 110
Wallace, A., Pehrson, A. L., Sánchez, C., & Morilak, D. A. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000571 · Cited by 97
Coplan, J. D., Gopinath, S., Abdallah, C. G., & Berry, B. R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00189 · Cited by 90
El Mansari, M., Ghanbari, R., Janssen, S., & Blier, P. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.028 · Cited by 63
Metadata
- Authors
- Blier, P., & De Montigny, C.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 1987-01
- Volume
- 1
- Issue
- 5
- Pages
- 470-480
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W2151662898
- Cited by
- 426
- References
- 37
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.